The latest price target for P3 Health Partners (NASDAQ:PIII) was reported by TD Cowen on April 2, 2026. The analyst firm set a price target for $3.00 expecting PIII to rise to within 12 months (a possible 22.45% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for P3 Health Partners (NASDAQ:PIII) was provided by TD Cowen, and P3 Health Partners maintained their hold rating.

There is no last upgrade for P3 Health Partners

The last downgrade for P3 Health Partners Inc happened on April 1, 2024 when BTIG changed their price target from N/A to N/A for P3 Health Partners Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of P3 Health Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for P3 Health Partners was filed on April 2, 2026 so you should expect the next rating to be made available sometime around April 2, 2027.

While ratings are subjective and will change, the latest P3 Health Partners (PIII) rating was a maintained with a price target of $8.00 to $3.00. The current price P3 Health Partners (PIII) is trading at is $2.45, which is out of the analyst’s predicted range.